Effects of Olanzapine on Bone Mineral Density, Glucose, and Lipid Metabolism in Schizophrenia Patients

AIM: To explore whether olanzapine alters bone mineral density (BMD), glucose, and lipid metabolism in schizophrenia patients. METHODS: This study enrolled 150 patients diagnosed with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), including 101 patients wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Endocrinol
Main Authors: Liang, Mining, Zhang, Beibei, Deng, Lu, Xu, Rong, Wu, Haishan, Chen, Jindong
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451798/
https://ncbi.nlm.nih.gov/pubmed/31019532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1312804
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados